Artelo Biosciences (ARTL) awards 136-share stock option grant
Rhea-AI Filing Summary
Artelo Biosciences director Gregory Reyes received a grant of stock options covering 136 shares of common stock at an exercise price of $1.15 per share, expiring July 17, 2036. All options vest 100% on the earlier of one year after the July 17, 2026 Vesting Commencement Date or the day before the next annual stockholder meeting, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Reyes Gregory
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 136 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 136 shares (Direct)
Footnotes (1)
- F1. Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 17, 2026.
Key Figures
Stock options granted: 136 shares
Exercise price: $1.15 per share
Expiration date: July 17, 2036
+1 more
4 metrics
Stock options granted
136 shares
Director stock option grant covering common stock
Exercise price
$1.15 per share
Exercise price of the granted stock options
Expiration date
July 17, 2036
Option expiration for the director grant
Vesting Commencement Date
July 17, 2026
Defined as the Vesting Commencement Date for the option
Key Terms
Stock Option (right to buy), Vesting Commencement Date, Service Provider
3 terms
Stock Option (right to buy) financial
"Security title reported as Stock Option (right to buy)."
Vesting Commencement Date financial
""Vesting Commencement Date" shall mean July 17, 2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider..."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Artelo Biosciences (ARTL) report for Gregory Reyes?
Artelo Biosciences reported that director Gregory Reyes received a grant of stock options covering 136 shares of common stock. The options carry a $1.15 exercise price per share, expire on July 17, 2036, and vest in full based on future service and meeting timing conditions.
What is the exercise price of Gregory Reyes’s Artelo Biosciences (ARTL) stock options?
The stock options granted to director Gregory Reyes have an exercise price of $1.15 per share. This is the fixed price at which he may purchase the 136 underlying common shares after the options vest, provided he remains a qualifying service provider.
When do Gregory Reyes’s Artelo Biosciences (ARTL) options vest?
All of Gregory Reyes’s options vest 100% on the earlier of one year after the July 17, 2026 Vesting Commencement Date or the day before the next annual stockholder meeting. Vesting is conditioned on his continued status as a service provider through the applicable date.
What is the expiration date of the stock options granted to Gregory Reyes at Artelo Biosciences (ARTL)?
The options granted to director Gregory Reyes expire on July 17, 2036. After this expiration date, any unexercised portion of the 136-share option grant will lapse, even if it has vested, consistent with the long-term nature of typical director equity compensation.
Are Gregory Reyes’s new Artelo Biosciences (ARTL) options immediately exercisable?
No. Gregory Reyes’s options vest 100% only after specific conditions are met: continued service through the vesting date and the earlier of one year after July 17, 2026 or the day before the next annual stockholder meeting. Exercise generally follows vesting and remains subject to plan terms.